605 related articles for article (PubMed ID: 19285657)
1. Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset.
Araki Y; Sotozono C; Inatomi T; Ueta M; Yokoi N; Ueda E; Kishimoto S; Kinoshita S
Am J Ophthalmol; 2009 Jun; 147(6):1004-11, 1011.e1. PubMed ID: 19285657
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
Sotozono C; Ueta M; Koizumi N; Inatomi T; Shirakata Y; Ikezawa Z; Hashimoto K; Kinoshita S
Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825
[TBL] [Abstract][Full Text] [Related]
3. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome.
Sotozono C; Ang LP; Koizumi N; Higashihara H; Ueta M; Inatomi T; Yokoi N; Kaido M; Dogru M; Shimazaki J; Tsubota K; Yamada M; Kinoshita S
Ophthalmology; 2007 Jul; 114(7):1294-302. PubMed ID: 17475335
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of treatments and deceased cases of severe adverse drug reactions--analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis].
Yamane Y; Aihara M; Tatewaki S; Matsukura S; Kanbara T; Yamakawa Y; Ikezawa Z
Arerugi; 2009 May; 58(5):537-47. PubMed ID: 19487835
[TBL] [Abstract][Full Text] [Related]
5. Systemic and local management at the onset of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
Sotozono C; Ueta M; Kinoshita S
Am J Ophthalmol; 2010 Feb; 149(2):354; author reply 355. PubMed ID: 20103059
[No Abstract] [Full Text] [Related]
6. Vision-related function after scleral lens fitting in ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Tougeron-Brousseau B; Delcampe A; Gueudry J; Vera L; Doan S; Hoang-Xuan T; Muraine M
Am J Ophthalmol; 2009 Dec; 148(6):852-9.e2. PubMed ID: 19837383
[TBL] [Abstract][Full Text] [Related]
7. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome.
Di Pascuale MA; Espana EM; Liu DT; Kawakita T; Li W; Gao YY; Baradaran-Rafii A; Elizondo A; Raju VK; Tseng SC
Ophthalmology; 2005 May; 112(5):904-12. PubMed ID: 15878074
[TBL] [Abstract][Full Text] [Related]
8. In vivo confocal microscopic evaluation of corneal changes in chronic Stevens-Johnson syndrome and toxic epidermal necrolysis.
Vera LS; Gueudry J; Delcampe A; Roujeau JC; Brasseur G; Muraine M
Cornea; 2009 May; 28(4):401-7. PubMed ID: 19411958
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis.
Kardaun SH; Jonkman MF
Acta Derm Venereol; 2007; 87(2):144-8. PubMed ID: 17340021
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
Yang Y; Xu J; Li F; Zhu X
Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
[TBL] [Abstract][Full Text] [Related]
11. The role of systemic immunomodulatory treatment and prognostic factors on chronic ocular complications in Stevens-Johnson syndrome.
Kim DH; Yoon KC; Seo KY; Lee HS; Yoon SC; Sotozono C; Ueta M; Kim MK
Ophthalmology; 2015 Feb; 122(2):254-64. PubMed ID: 25262319
[TBL] [Abstract][Full Text] [Related]
12. Amniotic membrane transplantation in acute phase of toxic epidermal necrolysis with severe corneal involvement.
Kobayashi A; Yoshita T; Sugiyama K; Miyashita K; Niida Y; Koizumi S; Tseng SC
Ophthalmology; 2006 Jan; 113(1):126-32. PubMed ID: 16324747
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
14. Topical Betamethasone Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis with Ocular Involvement in the Acute Phase.
Matsumoto K; Ueta M; Inatomi T; Fukuoka H; Mieno H; Tamagawa-Mineoka R; Katoh N; Kinoshita S; Sotozono C
Am J Ophthalmol; 2023 Sep; 253():142-151. PubMed ID: 37182731
[TBL] [Abstract][Full Text] [Related]
15. Functional visual acuity in Stevens-Johnson syndrome.
Kaido M; Dogru M; Yamada M; Sotozono C; Kinoshita S; Shimazaki J; Tsubota K
Am J Ophthalmol; 2006 Dec; 142(6):917-22. PubMed ID: 17157576
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acute Stevens-Johnson syndrome and toxic epidermal necrolysis using amniotic membrane: a review of 10 consecutive cases.
Gregory DG
Ophthalmology; 2011 May; 118(5):908-14. PubMed ID: 21440941
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing outcomes in cultivated limbal epithelial transplantation for chronic cicatricial ocular surface disorders.
Shimazaki J; Higa K; Morito F; Dogru M; Kawakita T; Satake Y; Shimmura S; Tsubota K
Am J Ophthalmol; 2007 Jun; 143(6):945-53. PubMed ID: 17459317
[TBL] [Abstract][Full Text] [Related]
18. Management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis utilizing amniotic membrane and topical corticosteroids.
Shammas MC; Lai EC; Sarkar JS; Yang J; Starr CE; Sippel KC
Am J Ophthalmol; 2010 Feb; 149(2):203-213.e2. PubMed ID: 20005508
[TBL] [Abstract][Full Text] [Related]
19. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
[TBL] [Abstract][Full Text] [Related]
20. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.
Chen J; Wang B; Zeng Y; Xu H
Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
